Filing Details
Envoy Medical, Inc. (NASDAQ:COCH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:COCH
Envoy Medical, Inc. (COCH) Files Quarterly Report for Q0
Envoy Medical, Inc. (NASDAQ:COCH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 10, 2026.
At publication ·
What changed
Envoy Medical, Inc. (NASDAQ:COCH) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Envoy Medical, Inc. (NASDAQ: COCH) filed its quarterly report (Form 10-Q) with the SEC on August 10, 2026.
- The company's stock trades at $0.70 per share with a market capitalization of $17.3 million.
- The quarterly report includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Envoy Medical, Inc.'s stock currently trades at $0.70 with a market capitalization of $17.3M.
The 10-Q provides Envoy Medical, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Envoy Medical, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View COCH Stock Page
Frequently Asked Questions
Where can I read COCH's SEC filings?
Browse all filings on our COCH SEC filings page.
What types of SEC filings does Envoy Medical, Inc. file?
Public companies like Envoy Medical, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.